Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerstein

Showing results (41-50 of 1,911) with videos related to

Pageof 192
Sort By:
Circulation Research|October 1, 2017
Letter by Calderón-Gerstein Regarding Article, "Environmental Determinants of Cardiovascular Disease"Walter Calderón-Gerstein
The New England Journal of Medicine|July 20, 2007
Prophylaxis for thromboembolism in hospitalized medical patientsWalter Calderón-Gerstein
NIDA Research Monograph|January 1, 1991
Policy-relevant research on drug treatmentD R Gerstein
Annals of Internal Medicine|September 24, 2004
Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factorHertzel C Gerstein
Diabetes Care|May 20, 1999
Is glucose a continuous risk factor for cardiovascular mortality?H C Gerstein
Annals of Internal Medicine|March 15, 1993
Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitusH C Gerstein
Evidence-Based Cardiovascular Medicine|December 29, 2005
Lisinopril inhibited the progression of renal albumin excretion in patients with insulin-dependent diabetes mellitusH C Gerstein
Comprehensive Therapy|January 1, 1994
Screening for postpartum thyroid dysfunctionH C Gerstein
JAMA|February 4, 2010
Does insulin therapy promote, reduce, or have a neutral effect on cancers?Hertzel C Gerstein
Diabetes Care|October 27, 2001
Fasting versus postload glucose levels: why the controversy?H C Gerstein
Pageof 192

Showing results (41-50 of 1,911) with videos related to

Sort By:
Pageof 192
Circulation Research|October 1, 2017
Letter by Calderón-Gerstein Regarding Article, "Environmental Determinants of Cardiovascular Disease"Walter Calderón-Gerstein
The New England Journal of Medicine|July 20, 2007
Prophylaxis for thromboembolism in hospitalized medical patientsWalter Calderón-Gerstein
NIDA Research Monograph|January 1, 1991
Policy-relevant research on drug treatmentD R Gerstein
Annals of Internal Medicine|September 24, 2004
Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factorHertzel C Gerstein
Diabetes Care|May 20, 1999
Is glucose a continuous risk factor for cardiovascular mortality?H C Gerstein
Annals of Internal Medicine|March 15, 1993
Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitusH C Gerstein
Evidence-Based Cardiovascular Medicine|December 29, 2005
Lisinopril inhibited the progression of renal albumin excretion in patients with insulin-dependent diabetes mellitusH C Gerstein
Comprehensive Therapy|January 1, 1994
Screening for postpartum thyroid dysfunctionH C Gerstein
JAMA|February 4, 2010
Does insulin therapy promote, reduce, or have a neutral effect on cancers?Hertzel C Gerstein
Diabetes Care|October 27, 2001
Fasting versus postload glucose levels: why the controversy?H C Gerstein
Pageof 192